Bajaj Healthcare launches Magnesium L-Threonate capsules
Bajaj Healthcare Limited (BHL), an Indian manufacturer of APIs, intermediates, and formulations, has launched Magnesium L-Threonate as part of its nutraceutical segment. The company has ... Read More
Bajaj Healthcare launches Covid drug 2-DG under DGJAJ brand
Bajaj Healthcare Limited (BHL) said that it has launched API and formulation of 2-Deoxy-D-Glucose (2-DG), an antiviral drug used for the treatment of moderate to ... Read More
Bajaj Healthcare launches API of Black Fungus drug Posaconazole
Bajaj Healthcare Limited (BHL) has launched “Posaconazole API”, the active pharmaceutical ingredient (API) of the triazole antifungal agent Posaconazole, used in the treatment of Mucormycosis ... Read More
Bajaj Healthcare launches Favijaj tablets for Covid-19 treatment in India
Bajaj Healthcare Limited (BHL) has launched Favijaj tablets, its generic version of Japan-based Fujifilm's antiviral drug favipiravir for the treatment of mild to moderate Covid-19 ... Read More